Finanzwire Finanzwire
Basculer en Français
10184 Companies
209559 Keywords
139675 Articles
111091 Press releases
Headlines Articles Press releases Hop On A Cure Remove
  1. Home
  2. Companies
  3. Hop On A Cure
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/09/2024 at 14:05, 1 year 9 months ago

    Hop On A Cure Makes Financial Contribution Toward ALS CURE Project

    Machine Learning Biomarkers Medical Research ALS Biometric Analysis
  • PRESS RELEASE

    published on 07/09/2024 at 14:00, 1 year 9 months ago

    Hop on a Cure Makes Financial Contribution Toward ALS CURE Project

    Hop On A Cure contributes to ALS CURE Project's 3ML Project, funding research on ALS biomarkers for early diagnosis and treatment. Impactful financial support from HOAC to accelerate ALS research
    Research Biomarkers ALS Hop On A Cure ALS CURE Project
    Logo of Hop On A Cure
  • BRIEF

    published on 04/24/2024 at 15:05, 1 year 11 months ago

    Hop on a Cure Donates $250,000 to Massachusetts General Hospital’s ALS Center

    Hop On A Cure ALS Research Massachusetts General Hospital Motor Neuron Regeneration Fundraising Activities
  • PRESS RELEASE

    published on 04/24/2024 at 15:00, 1 year 11 months ago

    Hop on a Cure Makes Financial Contribution Toward Massachusetts General Hospital’s Sean M. Healey & AMG Center for ALS

    Hop On A Cure donates $250,000 to Massachusetts General Hospital for ALS research, supporting innovative therapies and young talent in the field
    Donation Hop On A Cure ALS Research Massachusetts General Hospital Innovative Therapies
    Logo of Hop On A Cure
Accesswire
  • Published on 04/09/2026 at 16:00, 2 hours 34 minutes ago

    Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X

  • Published on 04/09/2026 at 14:40, 3 hours 54 minutes ago

    Silver X Delivers Production Growth During the First Quarter of 2026

  • Published on 04/09/2026 at 14:00, 4 hours 34 minutes ago

    Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty

  • Published on 04/09/2026 at 13:30, 5 hours 4 minutes ago

    Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

  • Published on 04/09/2026 at 13:30, 5 hours 4 minutes ago

    ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE
EQS Group
  • Published on 04/09/2026 at 18:15, 18 minutes ago

    REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares

  • Published on 04/09/2026 at 15:59, 2 hours 34 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:57, 2 hours 37 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:40, 2 hours 54 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

  • Published on 04/09/2026 at 15:39, 2 hours 54 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS
Les Echos
  • Published on 04/09/2026 at 17:35, 59 minutes ago

    SUEZ - FY 2025

  • Published on 04/09/2026 at 15:57, 2 hours 36 minutes ago

    Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports

  • Published on 04/09/2026 at 07:00, 11 hours 34 minutes ago

    bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

  • Published on 04/08/2026 at 18:02, 1 day ago

    Publication of the 2025 Universal Registration Document

  • Published on 04/08/2026 at 17:45, 1 day ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy